During a recent formulary management conference, PCS VP-Network Administration Douglas Stephens referred to a switch program for Miles Adalat CC as an example of pharmacists being paid to switch to manufacturers' products. Mylan was not involved in the program discussed by Stephens (1"The Pink Sheet" Aug. 9, p. 11)
You may also be interested in...
PCS Health Systems is working with the two manufacturers in its program to promote Rx switches to "preferred" formulary drugs, PCS VP-Network Administration Douglas Stephens told the Center for Business Intelligence's Pricing, Reimbursement & Formulary Management conference July 30 in Atlantic City.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials